Nabuton (Nabumetone)

Nabumetone, the active ingredient in Nabuton, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for oral use. It is indicated for the relief of pain and inflammation associated with osteoarthritis, rheumatoid arthritis and other musculoskeletal conditions in adult patients.

GNH USA supplies Nabuton as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for each batch. Clients benefit from reliable delivery timelines and dedicated technical support throughout the procurement process.

Nabuton (nabumetone) is used to manage inflammatory joint disorders by reducing prostaglandin‑mediated inflammation. - Osteoarthritis: reduces pain and improves joint function in patients with degenerative joint disease. - Rheumatoid arthritis: alleviates chronic inflammation and joint swelling in autoimmune arthritis. - Musculoskeletal pain: provides symptomatic relief for acute or chronic pain affecting muscles, tendons or ligaments.

Nabuton may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain. - Headache: mild to moderate intensity. - Dizziness: transient sensation of light‑headedness. - Elevated liver enzymes: mild increase detected in routine labs. - Skin rash: mild erythema or pruritus.

Serious or Rare Side Effects: - Peptic ulcer disease: gastrointestinal bleeding or perforation. - Severe hepatic injury: hepatitis or liver failure. - Renal impairment: acute kidney injury or worsening chronic kidney disease. - Cardiovascular events: myocardial infarction or stroke. - Anaphylaxis: severe allergic reaction with airway compromise.

Before prescribing Nabuton, clinicians should evaluate patient history and monitor for potential risks. - Assess renal function: check baseline creatinine and eGFR. - Evaluate hepatic status: avoid use in patients with active liver disease. - Review gastrointestinal history: caution in those with prior ulcers or bleeding. - Monitor cardiovascular risk: use cautiously in patients with heart disease. - Avoid concurrent NSAIDs: increase risk of bleeding and renal toxicity. - Store at ambient temperature: keep below 25 °C, protect from moisture and light.

Nabuton can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity. - ACE inhibitors or ARBs: may reduce renal function.

Moderate Interactions (Monitor Closely): - Diuretics: potential for reduced renal perfusion. - Lithium: NSAIDs may increase lithium levels. - Methotrexate: decreased clearance leading to toxicity.